ERBB2 and breast carcinoma: A study by Biabani et al. using [68Ga]Ga-DOTA-(Ser)3-LTVSPWY to assess HER2-positive breast cancer xenografts in mice showed high tumor affinity, with a significant decrease in uptake when blocked both in vitro and in vivo with an unlabeled peptide.